A prospective, open label, Phase I first-in-man trial of safety and tolerability of the humanized Clever-1 antibody (Clevegen)
- Shetty, Shishir (Principal Investigator)
- Adams, David (Co-Investigator)
- Rowe, Anna (Co-Investigator)
- Ma, Yuk (Co-Investigator)
- Gough, Richard (Co-Investigator)